Glevo Tablets (Levofloxacin) by Life Pharmaceutical Company
Drug Category: Quinolones/ Antibiotics, systemic
Indication: Levofloxacin is primarily indicated in conditions like Bronchiolitis, Bronchitis, Complicated UTIS, Folliculitis, Nephrogenic and partial pituitary diabetes insipidus, Oedema, Otitis externa, Pneumonia, Pyelonephritis, Respiratory tract infections, Short-term treatment of severe congestive heart failure, Skin and soft tissue infections.
Each Tablet contains:
- Levofloxacin……………………………250mg/ 500mg/ 750mg
- Levofloxacin: Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication and transcription is inhibited.